Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-06-25

FDA Approved: TRANEXAMIC ACID — Supplemental Application (XGen Pharmaceuticals DJB, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for tranexamic acid submitted by XGen Pharmaceuticals DJB, Inc. under an ANDA, indicating regulatory action related …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

SUPPL AP for TRANEXAMIC ACID (TRANEXAMIC ACID)